Rose BioSolutions welcomed David Enloe as Chief Executive Officer.

Rose BioSolutions is an advanced therapy CDMO engineered to deliver integrated cell and gene therapy development, manufacturing, and cellular starting materials. Our capabilities span the full continuum, from human cells and biospecimens to plasmid DNA, viral vector production, and cell therapy manufacturing, operating as one coordinated system. We bring the experience and infrastructure required to take programs from early research through commercial production. Built on deep scientific expertise and a commitment to precision, growth, and care, we are accelerating innovation in advanced therapies and expanding access to life-changing treatments.

Founded 2026